PHAXIAM Therapeutics S.A. Other Current Receivables
PHAXIAM Therapeutics S.A. had Other Current Receivables of EUR 1.25 million as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes › Receivables
ifrs-full:OtherCurrentReceivables · last filed 2023-09-26
- 2023-06-30: Other Current Receivables 1.25M EUR.
- 2022-12-31: Other Current Receivables 973.00K EUR.
- 2022-06-30: Other Current Receivables 973.00K EUR; Other Current Receivables as first filed 444.00K EUR.
- 2021-12-31: Other Current Receivables 669.00K EUR.
| Period end | Other Current Receivables | Other Current Receivables as first filed |
|---|---|---|
| 2023-06-30 | 1.25M EUR 6-K · filed 2023-09-26 | |
| 2022-12-31 | 973.00K EUR 20-F · filed 2023-03-28 | |
| 2022-06-30 | 973.00K EUR 6-K · filed 2023-09-26 | 444.00K EUR 6-K · filed 2022-09-12 |
| 2021-12-31 | 669.00K EUR 20-F · filed 2023-03-28 | |
| 2021-06-30 | 660.00K EUR 6-K · filed 2021-09-20 | |
| 2020-12-31 | 898.00K EUR 20-F · filed 2023-03-28 | |
| 2020-06-30 | 789.00K EUR 6-K · filed 2020-09-21 | |
| 2019-12-31 | 1.87M EUR 20-F · filed 2022-04-27 | 1.87M EUR 6-K · filed 2020-09-21 |
| 2018-12-31 | 1.95M EUR 20-F · filed 2021-03-08 |